Dr Reddy's Laboratories Q4 EPS $0.22 Beats $0.20 Estimate, Sales $996.00M Beat $866.51M Estimate

Benzinga · 05/09 19:01
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.20 by 10 percent. This is a 22.22 percent increase over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $996.00 million which beat the analyst consensus estimate of $866.51 million by 14.94 percent. This is a 20.14 percent increase over sales of $829.00 million the same period last year.